Piotr Zaleski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Piotr Zaleski has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Andrzej Plucienniczak
Institute of Biotechnology and Antibiotics, Starościńska 5, 02-516 Warsaw, Poland
4 shared publicationsAgnieszka Sobolewska
Instytut Biotechnologii i Antybiotyków , Warszawa Poland
3 shared publicationsAndrzej Płucienniczak
Bioengineering Department, Institute of Biotechnology and Antibiotics, Starościńska 5, 02-516, Warsaw, Poland
3 shared publications- Natalia Łukasiewicz
Institute of Biotechnology and Antibiotics, Starościńska 5, 02-516 Warsaw, Poland
3 shared publications Paweł Wawrzyniak
Instytut Biotechnologii i Antybiotyków , Warszawa Poland
3 shared publications- Piotr Kierył
Institute of Biotechnology and Antibiotics, Starościńska 5, 02-516 Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
- 13 November 2019
- Published by Springer Nature in BMC Microbiology
- Vol. 19 (1) , 1-15
Molecular dissection of the replication system of plasmid pIGRK encoding two in-frame Rep proteins with antagonistic functions
Background: Gene overlapping is a frequent phenomenon in microbial genomes. Excluding so-called “trivial overlapping”, there are significant implications of such genetic arrangements, including regulation of gene expression and modification of protein activity. It is also postulated that, besides gene duplication, the appearance of overlapping genes (OGs) is one of the most important factors promoting a genome’s novelty and evolution. OGs coding for in-frame proteins with different functions are a particularly interesting case. In this study we identified and characterized two in-frame proteins encoded by OGs on plasmid pIGRK fromKlebsiella pneumoniae, a representative of the newly distinguished pHW126 plasmid family.Results: A singlerepRlocus located within the replication system of plasmid pIGRK encodes, in the same frame, two functional polypeptides: a full-length RepR protein and a RepR’ protein (withN-terminal truncation) translated from an internal START codon. Both proteins form homodimers, and interact with diverse DNA regions within the plasmid replication origin andrepRpromoter operator. Interestingly, RepR and RepR’ have opposing functions – RepR is crucial for initiation of pIGRK replication, while RepR’ is a negative regulator of this process. Nevertheless, both proteins act cooperatively as negative transcriptional regulators of their own expression.Conclusions: Regulation of the initiation of pIGRK replication is a complex process in which a major role is played by two in-frame proteins with antagonistic functions. In-frame encoded Rep proteins are uncommon, having been described in only a few plasmids. This is the first description of such proteins in a plasmid of the pHW126 family.
- 13 November 2019
- Published by Springer Nature in BMC Microbiology
- Vol. 19 (1) , 1-15
Open AccessMolecular dissection of the replication system of plasmid pIGRK encoding two in-frame Rep proteins with antagonistic functions
Background: Gene overlapping is a frequent phenomenon in microbial genomes. Excluding so-called “trivial overlapping”, there are significant implications of such genetic arrangements, including regulation of gene expression and modification of protein activity. It is also postulated that, besides gene duplication, the appearance of overlapping genes (OGs) is one of the most important factors promoting a genome’s novelty and evolution. OGs coding for in-frame proteins with different functions are a particularly interesting case. In this study we identified and characterized two in-frame proteins encoded by OGs on plasmid pIGRK fromKlebsiella pneumoniae, a representative of the newly distinguished pHW126 plasmid family.Results: A singlerepRlocus located within the replication system of plasmid pIGRK encodes, in the same frame, two functional polypeptides: a full-length RepR protein and a RepR’ protein (withN-terminal truncation) translated from an internal START codon. Both proteins form homodimers, and interact with diverse DNA regions within the plasmid replication origin andrepRpromoter operator. Interestingly, RepR and RepR’ have opposing functions – RepR is crucial for initiation of pIGRK replication, while RepR’ is a negative regulator of this process. Nevertheless, both proteins act cooperatively as negative transcriptional regulators of their own expression.Conclusions: Regulation of the initiation of pIGRK replication is a complex process in which a major role is played by two in-frame proteins with antagonistic functions. In-frame encoded Rep proteins are uncommon, having been described in only a few plasmids. This is the first description of such proteins in a plasmid of the pHW126 family.
- Open Access
- 1 May 2019
- Published by Elsevier in Protein Expression and Purification
- Vol. 157, 63-69
Expression and purification of recombinant human insulin from E. coli 20 strain
- 1 May 2019
- Published by Elsevier in Protein Expression and Purification
- Vol. 157, 63-69
Open AccessExpression and purification of recombinant human insulin from E. coli 20 strain
- Open Access
- 1 January 2019
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 58 (1) , 87-100
Cell Banks Preparation In Biopharmaceuticals Production
The fast development of the biopharmaceutical market is correlated with the growing number and availability of technologies for the production of so-called biodrugs. One of the main procedures for therapeutic protein production is based on bacterial expression systems. In order to maintain the constant quality and homogeneity of the initial inoculum, the cell bank must be created in full accordance with quality standards. The first step should be the establishment of a Master Cell Bank (MCB), which must be performed in a laboratory that meets high quality standards and according to well-described main procedures. The MCB should be initiated from a single well-characterised bacterial colony. A Working Cell Bank (WCB) is usually prepared as a second step from one or few vials deposited in the MCB. The WCB must be characterised for bacterial strain homology and be free of any biological cross contamination. This paper describes the main requirements and good practises for the preparation of a cell bank suitable for constant and reproducible production of biopharmaceuticals. 1. Introduction. 2. Prokaryotic expression system. 3. Cell banking system. 4. Cell banks characterization. 4.1. Conformation of identity (properties) of the bacterial strain. 4.2. Confirmation of the purity of the bacterial strain. 5. Summary
- 1 January 2019
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 58 (1) , 87-100
Open AccessCell Banks Preparation In Biopharmaceuticals Production
The fast development of the biopharmaceutical market is correlated with the growing number and availability of technologies for the production of so-called biodrugs. One of the main procedures for therapeutic protein production is based on bacterial expression systems. In order to maintain the constant quality and homogeneity of the initial inoculum, the cell bank must be created in full accordance with quality standards. The first step should be the establishment of a Master Cell Bank (MCB), which must be performed in a laboratory that meets high quality standards and according to well-described main procedures. The MCB should be initiated from a single well-characterised bacterial colony. A Working Cell Bank (WCB) is usually prepared as a second step from one or few vials deposited in the MCB. The WCB must be characterised for bacterial strain homology and be free of any biological cross contamination. This paper describes the main requirements and good practises for the preparation of a cell bank suitable for constant and reproducible production of biopharmaceuticals. 1. Introduction. 2. Prokaryotic expression system. 3. Cell banking system. 4. Cell banks characterization. 4.1. Conformation of identity (properties) of the bacterial strain. 4.2. Confirmation of the purity of the bacterial strain. 5. Summary
- Open Access
- 1 January 2017
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 56 (2) , 214-225
Plasmids – vectors for gene therapy
The first confirmed transfer of genetic material in human was performed in 1990. Ever since, gene therapy was considered to be one of the best promising treatments of genetic diseases. The sine qua non of successful gene therapy are efficient genetic vectors. Recently, the most frequently used vectors in clinical trials for genetic therapies are virus-based and plasmid-based. A range of features makes plasmids useful for gene therapy, however, they have also some characteristics which make it difficult to consider plasmids as ideal vectors. The main goal of this article is to address and describe these unfavourable factors. 1. Introduction. 2. Natural modification of DNA as an obstacle to the use of plasmids for gene therapy. 3. Plasmid DNA usage safety. 4. Plasmid DNA entry into eucaryotic cells. 5. Post-entry fate of plasmid DNA in eucaryotic cells. 6. pDNA-based gene therapies. 7. Alternative routes of development of pDNA-based gene therapies. 7.1. Baktofection. 7.2. Alternative Gene Therapy – AGT. 7.3. Hydrogels. 7.4. DNA minicircles. 7.5. DNA ministrings. 8. Summary 1. Wstęp. 2. Naturalna modyfikacja DNA jako przeszkoda w stosowaniu plazmidów w terapii genowej. 3. Bezpieczeństwo użycia plazmidowego DNA. 4. Wprowadzenie pDNA do komórek eukariotycznych. 5. Los plazmidowego DNA po wprowadzeniu do komórek eukariotycznych. 6. Terapie genowe bazujące na pDNA. 7. Inne kierunki rozwoju terapii genowych opartych na plazmidowym DNA. 7.1 Baktofekcja. 7.2. Alternatywna terapia genowa (Alternative Gene Therapy – AGT). 7.3. Hydrożele. 7.4. Minikoliste DNA. 7.5. Mininici DNA. 8. Podsumowanie
- 1 January 2017
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 56 (2) , 214-225
Open AccessPlasmids – vectors for gene therapy
The first confirmed transfer of genetic material in human was performed in 1990. Ever since, gene therapy was considered to be one of the best promising treatments of genetic diseases. The sine qua non of successful gene therapy are efficient genetic vectors. Recently, the most frequently used vectors in clinical trials for genetic therapies are virus-based and plasmid-based. A range of features makes plasmids useful for gene therapy, however, they have also some characteristics which make it difficult to consider plasmids as ideal vectors. The main goal of this article is to address and describe these unfavourable factors. 1. Introduction. 2. Natural modification of DNA as an obstacle to the use of plasmids for gene therapy. 3. Plasmid DNA usage safety. 4. Plasmid DNA entry into eucaryotic cells. 5. Post-entry fate of plasmid DNA in eucaryotic cells. 6. pDNA-based gene therapies. 7. Alternative routes of development of pDNA-based gene therapies. 7.1. Baktofection. 7.2. Alternative Gene Therapy – AGT. 7.3. Hydrogels. 7.4. DNA minicircles. 7.5. DNA ministrings. 8. Summary 1. Wstęp. 2. Naturalna modyfikacja DNA jako przeszkoda w stosowaniu plazmidów w terapii genowej. 3. Bezpieczeństwo użycia plazmidowego DNA. 4. Wprowadzenie pDNA do komórek eukariotycznych. 5. Los plazmidowego DNA po wprowadzeniu do komórek eukariotycznych. 6. Terapie genowe bazujące na pDNA. 7. Inne kierunki rozwoju terapii genowych opartych na plazmidowym DNA. 7.1 Baktofekcja. 7.2. Alternatywna terapia genowa (Alternative Gene Therapy – AGT). 7.3. Hydrożele. 7.4. Minikoliste DNA. 7.5. Mininici DNA. 8. Podsumowanie
- Open Access
- 1 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-12
Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination ofβ-Lactam Resistance Genes among the Enterobacteriaceae
Antibiotic resistance determinants are frequently associated with plasmids and other mobile genetic elements, which simplifies their horizontal transmission. Several groups of plasmids (including replicons of the IncL/M incompatibility group) were found to play an important role in the dissemination of resistance genes encodingβ-lactamases. The IncL/M plasmids are large, broad host range, and self-transmissible replicons. We have identified and characterized two novel members of this group: pARM26 (isolated from bacteria inhabiting activated sludge from a wastewater treatment plant) and pIGT15 (originating from a clinical strain ofEscherichia coli). This instigated a detailed comparative analysis of all available sequences of IncL/M plasmids encodingβ-lactamases. The core genome of these plasmids is comprised of 20 genes with conserved synteny. Phylogenetic analyses of these core genes allowed clustering of the plasmids into four separate groups, which reflect their antibiotic resistance profiles. Examination of the biogeography of the IncL/M plasmids revealed that they are most frequently found in bacteria of the family Enterobacteriaceae originating from the Mediterranean region and Western Europe and that they are able to persist in various ecological niches even in the absence of direct antibiotic selection pressure.
- 1 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-12
Open AccessDiversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination ofβ-Lactam Resistance Genes among the Enterobacteriaceae
Antibiotic resistance determinants are frequently associated with plasmids and other mobile genetic elements, which simplifies their horizontal transmission. Several groups of plasmids (including replicons of the IncL/M incompatibility group) were found to play an important role in the dissemination of resistance genes encodingβ-lactamases. The IncL/M plasmids are large, broad host range, and self-transmissible replicons. We have identified and characterized two novel members of this group: pARM26 (isolated from bacteria inhabiting activated sludge from a wastewater treatment plant) and pIGT15 (originating from a clinical strain ofEscherichia coli). This instigated a detailed comparative analysis of all available sequences of IncL/M plasmids encodingβ-lactamases. The core genome of these plasmids is comprised of 20 genes with conserved synteny. Phylogenetic analyses of these core genes allowed clustering of the plasmids into four separate groups, which reflect their antibiotic resistance profiles. Examination of the biogeography of the IncL/M plasmids revealed that they are most frequently found in bacteria of the family Enterobacteriaceae originating from the Mediterranean region and Western Europe and that they are able to persist in various ecological niches even in the absence of direct antibiotic selection pressure.
- Open Access
- 2 November 2011
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 326 (1) , 76-82
Mobilizable narrow host range plasmids as natural suicide vectors enabling horizontal gene transfer among distantly related bacterial species
Klebsiella pneumoniae 287-w carries three small narrow host range (NHR) plasmids (pIGMS31, pIGMS32, and pIGRK), which could be maintained in several
- 2 November 2011
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 326 (1) , 76-82
Open AccessMobilizable narrow host range plasmids as natural suicide vectors enabling horizontal gene transfer among distantly related bacterial species
Klebsiella pneumoniae 287-w carries three small narrow host range (NHR) plasmids (pIGMS31, pIGMS32, and pIGRK), which could be maintained in several
- Open Access
- 1 October 2005
- Published by Microbiology Society in Microbiology
- Vol. 151 (10) , 3361-3369
The role of Dam methylation in phase variation of Haemophilus influenzae genes involved in defence against phage infection
Haemophilus influenzae uses phase variation (PV) to modulate the activity of its defence systems against phage infection. The PV of the restriction–modification (R-M) system HindI, the main defence system against phage infection and incoming chromosomal and phage DNA in H. influenzae Rd, is driven by changes of the pentanucleotide repeat tract within the coding sequence of the hsdM gene and is influenced by lack of Dam methylation. Phase-variable resistance/sensitivity to phage infection correlates with changes in lipooligosaccharide (LOS) structure and occurs by slippage of tetranucleotide repeats within the gene lic2A, coding for a step in the biosynthesis of LOS. The lack of Dam activity destabilizes the tetranuclotide (5′-CAAT) repeat tract and increases the frequency of switching from sensitivity to resistance to phage infection more than in the opposite direction. The PV of the lgtC gene does not influence resistance or sensitivity to phage infection. Insertional inactivation of lic2A, but not lgtC or lgtF, leads to resistance to phage infection and to the same structure of the LOS as observed among phase-variable phage-resistant variants. This indicates that in the H. influenzae Rd LOS only the first two sugars (Glc-Gal) extending from the third heptose are part of bacterial phage receptors.
- 1 October 2005
- Published by Microbiology Society in Microbiology
- Vol. 151 (10) , 3361-3369
Open AccessThe role of Dam methylation in phase variation of Haemophilus influenzae genes involved in defence against phage infection
Haemophilus influenzae uses phase variation (PV) to modulate the activity of its defence systems against phage infection. The PV of the restriction–modification (R-M) system HindI, the main defence system against phage infection and incoming chromosomal and phage DNA in H. influenzae Rd, is driven by changes of the pentanucleotide repeat tract within the coding sequence of the hsdM gene and is influenced by lack of Dam methylation. Phase-variable resistance/sensitivity to phage infection correlates with changes in lipooligosaccharide (LOS) structure and occurs by slippage of tetranucleotide repeats within the gene lic2A, coding for a step in the biosynthesis of LOS. The lack of Dam activity destabilizes the tetranuclotide (5′-CAAT) repeat tract and increases the frequency of switching from sensitivity to resistance to phage infection more than in the opposite direction. The PV of the lgtC gene does not influence resistance or sensitivity to phage infection. Insertional inactivation of lic2A, but not lgtC or lgtF, leads to resistance to phage infection and to the same structure of the LOS as observed among phase-variable phage-resistant variants. This indicates that in the H. influenzae Rd LOS only the first two sugars (Glc-Gal) extending from the third heptose are part of bacterial phage receptors.